[Alterations in hepatitic metabolism induced by prolonged-action nifedipine in Mexican population].
Palma-Aguirre
José Antonio
JA
Unidad de Investigacion Médica en Farmacología, Hospital de Especialidades, Centro Médico Nacional Siglo XXI, IMSS Apartado postal 73-032, 03020, México, D.F.
Campos-Lara
María
M
Chávez-Negrete
Adolfo
A
D019540:Area Under Curve; D002121:Calcium Channel Blockers / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D051544:Cytochrome P-450 CYP3A; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D003692:Delayed-Action Preparations; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D008099:Liver / Q000187:drug effects / Q000378:metabolism* / Q000503:physiopathology; D008800:Mexico; D009543:Nifedipine / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D018570:Risk Assessment
D002121:Calcium Channel Blockers; D003692:Delayed-Action Preparations; D003577:Cytochrome P-450 Enzyme System; C104464:CYP3A protein, human; D051544:Cytochrome P-450 CYP3A; D009543:Nifedipine